Location: New York, NY
CIK: 0001493215 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $8.116B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,993,687 | $914M | 11.3% | $231.65 | +61.0% | COM | 558868105 |
| ARGX | ARGENX SE | 673,497 | $497M | 6.1% | $351.97 | — | SPONSORED ADR | 04016X101 |
| RNAM | AVIDITY BIOSCIENCES INC | 11,372,829 | $496M | 6.1% | $27.49 | +47.1% | COM | 05370A108 |
| PTCT | PTC THERAPEUTICS INC | 7,746,415 | $475M | 5.9% | $38.50 | +35.3% | COM | 69366J200 |
| INSM | INSMED INC | 3,084,558 | $444M | 5.5% | $30.62 | +300.0% | COM PAR $.01 | 457669307 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,756,277 | $382M | 4.7% | $23.47 | +142.2% | COM | 74366E102 |
| NTRA | NATERA INC | 2,000,000 | $322M | 4.0% | $42.76 | +269.9% | COM | 632307104 |
| — | AKERO THERAPEUTICS INC | 5,477,561 | $260M | 3.2% | $26.03 | — | COM | 00973Y108 |
| QURE | UNIQURE NV | 4,424,968 | $258M | 3.2% | $12.98 | +39.9% | SHS | N90064101 |
| PEN | PENUMBRA INC | 866,499 | $220M | 2.7% | $247.59 | +1.9% | COM | 70975L107 |
| RDNT | RADNET INC | 2,815,544 | $215M | 2.6% | $46.37 | +40.0% | COM | 750491102 |
| — | MERUS N V | 2,025,277 | $191M | 2.3% | $34.07 | — | COM | N5749R100 |
| TARS | TARSUS PHARMACEUTICALS INC | 3,177,436 | $189M | 2.3% | $25.98 | +89.5% | COM | 87650L103 |
| SYK | STRYKER CORPORATION | 490,000 | $181M | 2.2% | $348.93 | +10.2% | COM | 863667101 |
| IMCR | IMMUNOCORE HLDGS PLC | 4,869,798 | $177M | 2.2% | $43.23 | — | ADS | 45258D105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 7,144,524 | $152M | 1.9% | $21.24 | +11.3% | COM | 004225108 |
| CYTK | CYTOKINETICS INC | 2,721,158 | $150M | 1.8% | $29.14 | +41.4% | COM NEW | 23282W605 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,062,072 | $149M | 1.8% | $114.68 | +18.2% | COM | 64125C109 |
| AXSM | AXSOME THERAPEUTICS INC | 1,118,883 | $136M | 1.7% | $56.00 | +101.2% | COM | 05464T104 |
| STOK | STOKE THERAPEUTICS INC | 5,123,525 | $120M | 1.5% | $22.20 | -22.8% | COM | 86150R107 |
| APGE | APOGEE THERAPEUTICS INC | 2,712,097 | $108M | 1.3% | $27.01 | +41.3% | COM | 03770N101 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 2,588,831 | $106M | 1.3% | $28.18 | +45.0% | COM | G31249108 |
| MASI | MASIMO CORP | 683,294 | $101M | 1.2% | $166.52 | -9.1% | COM | 574795100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 3,258,266 | $98.01M | 1.2% | $40.76 | -26.4% | COM | 90400D108 |
| GH | GUARDANT HEALTH INC | 1,481,033 | $92.53M | 1.1% | $48.77 | +11.5% | COM | 40131M109 |
| URGN | UROGEN PHARMA LTD | 4,543,895 | $90.65M | 1.1% | $14.29 | +25.6% | COM | M96088105 |
| ISRG | INTUITIVE SURGICAL INC | 202,456 | $90.54M | 1.1% | $553.02 | -13.2% | COM NEW | 46120E602 |
| GHRS | GH RESEARCH PLC | 5,569,564 | $79.64M | 1.0% | $14.91 | -6.1% | ORDINARY SHARES | G3855L106 |
| TSHA | TAYSHA GENE THERAPIES INC | 24,354,291 | $79.64M | 1.0% | $1.88 | +51.0% | COM SHS | 877619106 |
| ZLAB | ZAI LAB LTD | 2,291,372 | $77.65M | 1.0% | $31.12 | — | ADR | 98887Q104 |
| IMTX | IMMATICS N.V | 8,815,617 | $75.11M | 0.9% | $10.04 | -38.7% | SHS | N44445109 |
| XNCR | XENCOR INC | 6,221,054 | $72.97M | 0.9% | $13.81 | -37.2% | COM | 98401F105 |
| CGON | CG ONCOLOGY INC | 1,701,216 | $68.52M | 0.8% | $36.07 | -19.4% | COM | 156944100 |
| BBNX | BETA BIONICS INC | 3,299,191 | $65.55M | 0.8% | $18.64 | -5.7% | COM | 08659B102 |
| SYRE | SPYRE THERAPEUTICS INC | 3,621,996 | $60.7M | 0.7% | $20.99 | -22.3% | COM NEW | 00773J202 |
| RCKT | ROCKET PHARMACEUTICALS INC | 17,687,772 | $57.66M | 0.7% | $17.75 | -82.3% | COM | 77313F106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,291,747 | $55.57M | 0.7% | $16.90 | — | SPONSORED ADS | 152309100 |
| ALKS | ALKERMES PLC | 1,672,356 | $50.17M | 0.6% | $27.15 | +3.9% | SHS | G01767105 |
| CMPS | COMPASS PATHWAYS PLC | 8,707,390 | $49.89M | 0.6% | $3.33 | — | SPONSORED ADS | 20451W101 |
| COGT | COGENT BIOSCIENCES INC | 3,467,486 | $49.79M | 0.6% | $11.85 | 0.0% | COM | 19240Q201 |
| VSTM | VERASTEM INC | 5,426,306 | $47.91M | 0.6% | $6.40 | +16.3% | COM NEW | 92337C203 |
| DGX | QUEST DIAGNOSTICS INC | 250,000 | $47.65M | 0.6% | $170.08 | +3.9% | COM | 74834L100 |
| LENZ | LENZ THERAPEUTICS INC | 863,389 | $40.22M | 0.5% | $20.79 | +76.9% | COM | 52635N103 |
| RAPT | RAPT THERAPEUTICS INC | 1,470,499 | $37.92M | 0.5% | $7.63 | +71.5% | COM NEW | 75382E208 |
| ORKA | ORUKA THERAPEUTICS INC | 1,945,649 | $37.41M | 0.5% | $34.29 | -56.8% | COM | 687604108 |
| DYN | DYNE THERAPEUTICS INC | 2,890,567 | $36.57M | 0.5% | $20.42 | -44.1% | COM | 26818M108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 872,387 | $36.33M | 0.4% | $31.39 | +1.9% | COM | 22663K107 |
| AQST | AQUESTIVE THERAPEUTICS INC | 6,250,000 | $34.94M | 0.4% | $4.32 | 0.0% | COM | 03843E104 |
| ABVX | ABIVAX SA | 350,000 | $29.71M | 0.4% | $84.90 | — | SPONSORED ADS | 00370M103 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 393,500 | $29.55M | 0.4% | $83.06 | -10.3% | COMMON STOCK | 36266G107 |
| REPL | REPLIMUNE GROUP INC | 6,395,732 | $26.8M | 0.3% | $7.33 | -12.8% | COM | 76029N106 |
| NGNE | NEUROGENE INC | 1,362,456 | $23.61M | 0.3% | $34.49 | -41.8% | COM | 64135M105 |
| BLTE | BELITE BIO INC | 312,500 | $23.13M | 0.3% | $74.00 | — | SPONSORED ADS | 07782B104 |
| ALEC | ALECTOR INC | 6,990,806 | $20.69M | 0.3% | $2.20 | 0.0% | COM | 014442107 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 8,306,063 | $20.6M | 0.3% | $10.12 | -72.7% | COM | 68572M106 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,679,479 | $19.75M | 0.2% | $7.47 | -31.4% | COM | 221015100 |
| XGN | EXAGEN INC | 1,696,866 | $18.65M | 0.2% | $11.21 | -21.0% | COM | 30068X103 |
| HTFL | HEARTFLOW INC | 495,000 | $16.66M | 0.2% | $32.24 | 0.0% | COM | 42238D107 |
| TEM | TEMPUS AI INC | 200,000 | $16.14M | 0.2% | $53.98 | +29.7% | CL A | 88023B103 |
| JBIO | JADE BIOSCIENCES INC | 1,449,273 | $12.51M | 0.2% | $33.31 | -75.5% | COM NEW | 008064206 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,461,500 | $11.04M | 0.1% | $1.61 | +39.7% | COM | 23284F105 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,705,960 | $10.12M | 0.1% | $19.93 | -63.3% | COM | 230031106 |
| LRMR | LARIMAR THERAPEUTICS INC | 3,125,000 | $10.09M | 0.1% | $3.75 | 0.0% | COM | 517125100 |
| CMPX | COMPASS THERAPEUTICS INC | 2,500,000 | $8.75M | 0.1% | $3.16 | 0.0% | COM | 20454B104 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 742,500 | $7.841M | 0.1% | $10.07 | +5.1% | CL A ORD SHS | G70077105 |
| PEPG | PEPGEN INC | 1,500,000 | $6.93M | 0.1% | $1.61 | 0.0% | COM | 713317105 |
| WVE | WAVE LIFE SCIENCES LTD | 900,000 | $6.588M | 0.1% | $5.98 | +35.4% | SHS | Y95308105 |
| ALUR | ALLURION TECHNOLOGIES INC | 2,542,603 | $5.212M | 0.1% | $3.30 | -24.5% | COMMON STOCK | 02008G201 |
| MIST | MILESTONE PHARMACEUTICALS IN | 2,506,102 | $5.012M | 0.1% | $20.06 | -91.2% | COM | 59935V107 |
| OMDA | OMADA HEALTH INC | 200,000 | $4.422M | 0.1% | $17.31 | +18.3% | COM | 68170A108 |
| TENX | TENAX THERAPEUTICS INC | 378,346 | $2.879M | 0.0% | $6.41 | -4.8% | COM NEW | 88032L605 |
| IMA | IMAGENEBIO INC | 334,445 | $2.726M | 0.0% | $13.25 | 0.0% | COM | 45175G207 |
| ADGM | ADAGIO MED HLDGS INC | 209,361 | $406K | 0.0% | $4.76 | -67.4% | COM | 00534B100 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 350,000 | $13,720 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |